
---
title: '公告精选：华友钴业、中伟股份拟向特斯拉供应三元前驱体产品；艾比森中报拟10派15元'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=2496'
author: 证券时报网
comments: false
date: Sun, 31 Jul 2022 18:58:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=2496'
---

<div>   
<p>证券时报e公司讯，7月31日晚间公告精选：<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603799" style="color: #2f67d1;text-decoration: none;" code="603799" target="_blank">华友钴业</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300919" style="color: #2f67d1;text-decoration: none;" code="300919" target="_blank">中伟股份</a>拟向特斯拉供应电池材料三元前驱体产品；<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002096" style="color: #2f67d1;text-decoration: none;" code="002096" target="_blank">南岭民爆</a>拟53.57亿元购买易普力95.54%股份；<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002432" style="color: #2f67d1;text-decoration: none;" code="002432" target="_blank">九安医疗</a>美国子公司日常经营重大合同履行完毕；<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002883" style="color: #2f67d1;text-decoration: none;" code="002883" target="_blank">中设股份</a>控股股东、实控人拟变更为无锡交通集团；<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300428" style="color: #2f67d1;text-decoration: none;" code="300428" target="_blank">立中集团</a>拟发行可转债募资不超15.8亿元，用于新能源锂电新材料项目等；<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300389" style="color: #2f67d1;text-decoration: none;" code="300389" target="_blank">艾比森</a>上半年扭亏为盈，拟10派15元；<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300887" style="color: #2f67d1;text-decoration: none;" code="300887" target="_blank">谱尼测试</a>上半年净利同比增243.94%；<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS605167" style="color: #2f67d1;text-decoration: none;" code="605167" target="_blank">利柏特</a>子公司签订15至20亿元总承包合同；<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300630" style="color: #2f67d1;text-decoration: none;" code="300630" target="_blank">普利制药</a>注射用伏立康唑获得新西兰药品管理局上市许可；<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ301071" style="color: #2f67d1;text-decoration: none;" code="301071" target="_blank">力量钻石</a>向特定对象发行股票申请获证监会注册批复。</p>

                  
</div>
            